NMS-P937, a 4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline derivative as potent and selective Polo-like kinase 1 inhibitor.
作者:
主题词
投药, 口服(Administration, Oral);动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞周期蛋白质类(Cell Cycle Proteins);细胞增殖(Cell Proliferation);临床试验, Ⅰ期(主题)(Clinical Trials, Phase I as Topic);半数抑制浓度(Inhibitory Concentration 50);小鼠(Mice);小鼠, 裸(Mice, Nude);分子结构(Molecular Structure);肿瘤(Neoplasms);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质类(Proto-Oncogene Proteins);吡唑类(Pyrazoles);喹唑啉类(Quinazolines);构效关系(Structure-Activity Relationship);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1016/j.bmcl.2011.03.054
PMID
21470862
发布时间
2023-12-13
- 浏览9
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文